Valuation: Peptron, Inc.

Market Cap 2,178B 1.62B 1.45B 1.34B 1.22B 2.3B 152B 2.37B 16.04B 6.39B 81.4B 6.08B 5.95B 257B P/E 2024
-96x
P/E 2025 -427x
Enterprise Value 2,100B 1.56B 1.4B 1.29B 1.17B 2.22B 147B 2.28B 15.47B 6.16B 78.5B 5.87B 5.74B 248B EV / Sales 2024
716x
EV / Sales 2025 1,037x
Free-Float
91.5%
Yield 2024 *
-
Yield 2025 -
1 day+0.11%
1 week-1.48%
Current month+1.19%
1 month+2.08%
3 months-48.62%
6 months-63.66%
Current year-63.23%
1 week 85,500
Extreme 85500
100,300
1 month 79,200
Extreme 79200
110,700
Current year 79,200
Extreme 79200
359,000
1 year 79,200
Extreme 79200
392,500
3 years 21,100
Extreme 21100
392,500
5 years 7,050
Extreme 7050
392,500
10 years 7,050
Extreme 7050
392,500
Manager TitleAgeSince
Chief Executive Officer 65 29/03/2021
Chief Executive Officer 60 20/11/1997
Director of Finance/CFO 60 -
Director TitleAgeSince
Director/Board Member 60 30/03/2015
Director/Board Member 60 30/06/1999
Director/Board Member 65 29/03/2021
Date Insider Type Main position Quantity % Market Cap. Importance
27/11/24 Exercice

Chief Executive Officer

111,462 0.4799%
27/11/24 Exercice

Chief Financial Officer

8,709 0.0375%
27/11/24 Exercice

Chief Financial Officer

8,545 0.0368%
Change 5-day change 1-year change 3-year change Capi.($)
+0.11%-1.48%-67.34%+187.38% 1.62B
+0.01%+8.40%+58.48%+69.01% 68.22B
+1.22%+9.56%+15.97%+90.23% 59.82B
+0.24%+1.35%+23.78%+97.55% 56.07B
+1.08%+18.65%+27.95%+111.54% 47.67B
-1.37%+4.68%+29.02%+40.26% 45.95B
-4.60%-1.52%+204.93%+870.50% 43.29B
-3.33%+5.73%+23.28%+47.32% 35.66B
-2.19%-3.71%+90.94%+66.33% 34.73B
+1.99%+13.98%-37.97%+401.22% 25.47B
Average -0.70%+4.78%+36.90%+198.13% 42B
Weighted average by Cap. -0.67%+5.38%+49.53%+179.07%

Financials

2024 2025
Net sales 3.15B 2.35M 2.1M 1.94M 1.76M 3.33M 220M 3.42M 23.21M 9.25M 118M 8.8M 8.62M 372M 5.63B 4.19M 3.76M 3.47M 3.15M 5.96M 393M 6.12M 41.49M 16.53M 211M 15.73M 15.4M 666M
Net income -22.03B -16.39M -14.7M -13.55M -12.3M -23.29M -1.54B -23.94M -162M -64.64M -823M -61.52M -60.22M -2.6B -13.82B -10.29M -9.22M -8.5M -7.72M -14.61M -964M -15.02M -102M -40.55M -517M -38.6M -37.78M -1.63B
Net Debt -115B -85.31M -76.51M -70.51M -64.03M -121M -8B -125M -844M -336M -4.29B -320M -313M -13.55B -77.36B -57.56M -51.62M -47.57M -43.2M -81.77M -5.4B -84.05M -570M -227M -2.89B -216M -211M -9.14B
Projected Income Statement - Annual - Peptron, Inc.
Logo Peptron, Inc.
Peptron Inc is a Korea-based company principally engaged in the development, manufacture and distribution of sustained-release medications. The Company mainly develops the sustained-release medications and produces peptides as drug materials mainly for prostate cancer, hyperpituitarism, diabetes and neurodegenerative disorders. The Company also provides peptide synthesis services and manufactures raw material medicines. The Company distributes its products within domestic market and to overseas markets.
Employees
-
Date Price Change Volume
09/11/26 ₩93,400.00 +0.11% 97,701
09/11/26 ₩93,300.00 -4.11% 159,654
06/11/26 ₩97,300.00 +3.84% 219,586
05/11/26 ₩93,700.00 0.00% 165,018
04/11/26 ₩93,700.00 -3.30% 192,341
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
CCC
  1. Stock Market
  2. Stocks
  3. A087010 Stock